Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

 

Elizabeth Livengood, NMD - LDN and MDD: A Case Study - Treating Depression in Patients with Autoimmune Conditions (2019 Conference) (LDN, low dose naltrexone)

 

Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

 

LDN 2019 Conference - Friday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

 

Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

 

Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under-Appreciated (2019 Conference) (LDN, low dose naltrexone)

 

Elissa Mullen, ND - Sleep - PTSD HPA Axis Dysregulation - LDN & The Gut Brain Barrier (2019 Conference) (LDN, low dose naltrexone)

She describes sleep dysregulation and presents patient cases and relevant research.

Dr Richard Nahas, LDN Radio Show 2014 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health.

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today.